Target intelligence / Profile preview

Respiratory tract airflow

Molecular classification
Other (Physiological process), Physical medium
01

Overview

Respiratory tract airflow refers to the bulk movement of gas through the conducting airways of the respiratory system, driven by pressure gradients between the atmosphere and the alveoli (StatPearls, NBK537109). While not a molecular target or receptor, the bulk airway gas column is a critical physiological entity that serves as the medium for gas exchange and the delivery of inhaled therapeutics (NIH, How Lungs Work). In conditions such as asthma or chronic obstructive pulmonary disease (COPD), airflow is compromised by increased resistance, which can be addressed by pharmacological agents that dilate the airways or by medical gases like Heliox that alter the physical properties of the gas column itself (PubMed, 16433601). Interventions targeting this process aim to optimize ventilation-perfusion matching and reduce the work of breathing. Monitoring airflow through spirometry and other pulmonary function tests is essential for diagnosing respiratory diseases and assessing treatment efficacy. The physical characteristics of the gas column, such as Reynolds number and flow velocity, determine the efficiency of oxygen delivery and carbon dioxide removal.

Other names
Bulk airway gas columnAirway ventilationPulmonary airflowTracheobronchial gas flowConvective gas transport
02

Mechanism of action

Interventions targeting respiratory tract airflow involve altering the physical properties of the gas (e.g., density and viscosity) to promote laminar flow or modulating airway diameter to reduce resistance and improve gas delivery to the alveoli (StatPearls, NBK537109; PubMed, 16433601).

03

Biological functions

Gas exchangeVentilationAcid-base balanceHumidificationThermoregulation
04

Disease associations

AsthmaChronic obstructive pulmonary disease (COPD)Respiratory failureCystic fibrosisObstructive sleep apneaAcute respiratory distress syndrome (ARDS)
05

Safety considerations

BarotraumaOxygen toxicityHypercapniaVentilator-induced lung injuryAirway collapseAtelectasis
06

Interacting drugs

Heliox (Helium/Oxygen mixture)

5 more in the full profile.

07

Biomarkers

Forced expiratory volume in 1 second (FEV1)Peak expiratory flow rate (PEFR)Airway resistance (Raw)Fractional exhaled nitric oxide (FeNO)Airway conductance (Gaw)

Beyond the preview

Go deeper on Respiratory tract airflow.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Respiratory tract airflow.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call